Enzymase International

KBO/BCE: BE 0412.663.041

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	nothing on record	not filed	-
31-12-2023	31-07-2024	nothing on record	not filed	-
31-12-2022	31-07-2023	nothing on record	not filed	-
31-12-2021	31-07-2022	nothing on record	not filed	-
31-12-2020	31-07-2021	nothing on record	not filed	-
31-12-2019	31-07-2020	nothing on record	not filed	-
31-12-2018	31-07-2019	11-06-2019	50 d early	2019-16800334
31-12-2017	31-07-2018	27-06-2018	34 d early	2018-22900384
31-12-2016	31-07-2017	25-10-2017	86 d late	2017-67500297
31-12-2015	31-07-2016	10-06-2016	51 d early	2016-16400288
31-12-2014	31-07-2015	17-05-2015	75 d early	2015-12400493

Line item	Code	2018
Balance sheet, Assets
TOTAL ASSETS	20/58	€793k
Fixed assets	21/28	€12k
Financial fixed assets	28	€12k
Current assets	29/58	€781k
Amounts receivable within one year	40/41	€540k
Investments	50/53	€234k
Cash & bank	54/58	€7k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€793k
Equity	10/15	€-197k
Contributions / capital	10/11	€125k
Reserves	13	€12k
Accumulated profits (losses)	14	€-334k
Amounts payable	17/49	€990k
Amounts payable after one year	17	€234k
Amounts payable within one year	42/48	€747k
Trade debts payable within one year	44	€424k
Income statement
Gross operating margin	9900	€70k
Operating result	9901	€-54k
Financial charges	65	€18k
Result before taxes	9903	€-72k
Net result for the period	9904	€-72k
Result to be appropriated	9905	€-72k

Summary